Platinum drugs in the treatment of non-small-cell lung cancer.

Br J Cancer · 2002 · PMC2376170 · PMID 12373594

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The MVP regimen showed a trend towards a higher response rate than the other regimens in certain trials with no benefit on survival ( Ruckdeschel et al , 1985 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.